Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial

Background  Among medically ill patients treated with thromboprophylaxis, betrixaban was not associated with an increase in major bleeding compared with enoxaparin, but an increase in clinically relevant non-major (CRNM) bleeding was observed. The aim of this analysis is to describe the severity and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:TH Open
Main Authors: Yee, Megan K., Gibson, C. Michael, Nafee, Tarek, Kerneis, Mathieu, Daaboul, Yazan, Korjian, Serge, Chi, Gerald, AlKhalfan, Fahad, Hernandez, Adrian F., Hull, Russell D., Cohen, Alexander T., Goldhaber, Samuel Z.
Formato: Artigo
Idioma:Inglês
Publicado em: Georg Thieme Verlag KG 2019
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524922/
https://ncbi.nlm.nih.gov/pubmed/31249989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0039-1685496
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados